Dr. Markus Weissbach

Dr. Markus Weissbach is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as a Senior Clinical Development Consultant at HepaRegeniX GmbH since July 2021. Dr. Weissbach holds multiple leadership roles, including Chief Operating Officer at DS Biopharma and Chief Medical Officer at Afimmune Ltd, both since September 2017. As a founding partner of EHCor Consult GmbH since March 2013, Dr. Weissbach has consulted for various companies, including Takeda Vaccines and CytoTools AG. Other notable positions include Chief Medical Officer at ResoTher Pharma and Chief Executive Officer at Avesthagen Pharma AG, as well as leadership roles within Novartis Vaccines and Diagnostics and ICON Clinical Research. Dr. Weissbach earned a medical degree (Dr. med) from The University of Freiburg from 1976 to 1982.